Search - tctmd.com

Displaying 221 - 235 of 235

Sort: Relevancy | Date

News Daily News

Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals

Michael O'Riordan

January 16, 2020

News Daily News

Coconut Oil Ups LDL Cholesterol Compared With Other Fats: Meta-analysis

Yael L. Maxwell

January 16, 2020

News Daily News

No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry

Todd Neale

January 15, 2020

News Daily News

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

Michael O'Riordan

January 14, 2020

News Daily News

For Some, Routine Cardiac Monitoring May Be Unnecessary After PCI

L.A. McKeown

January 13, 2020

News Daily News

Community Death Rates Following Type 2 MI Speak to Lack of Treatments, Trials

Yael L. Maxwell

January 10, 2020

News Daily News

New AUC for Cardiac Imaging Follow-up in Congenital Heart Disease

Michael O'Riordan

January 10, 2020

News Daily News

EACTS Offers to Help to Resolve EXCEL Controversy, as CRF Launches Review

Michael O'Riordan

January 08, 2020

News Daily News

Diastolic BP, Heart Rate Strongly Linked to Death in Chronic Aortic Regurgitation

Todd Neale

January 08, 2020

News Opinion Editor's Corner

The Biggest News of 2019: TCTMD’s Top 10

Shelley Wood

January 01, 2020

Presentation Live Valves 2019

Valve Guidelines: How Effective are They?

Presenter: Volkmar Falk

December 10, 2019

Presentation Cardiovascular Interventions 2019

Quality with Efficiency 12 by 12

Presenter: Richard Shlofmitz

November 01, 2019

Video

Valve Guidelines- How Effective Are They- - V. Falk

January 9, 2020

CME

Optimizing the Duration of DAPT following PCI

Partner Content

Looking Beyond the Stent: Optimizing LDL-C Management in Patients Undergoing Revascularization

October 8, 2020

Advertisement

Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals

Coconut Oil Ups LDL Cholesterol Compared With Other Fats: Meta-analysis

No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

For Some, Routine Cardiac Monitoring May Be Unnecessary After PCI

Community Death Rates Following Type 2 MI Speak to Lack of Treatments, Trials

New AUC for Cardiac Imaging Follow-up in Congenital Heart Disease

EACTS Offers to Help to Resolve EXCEL Controversy, as CRF Launches Review

Diastolic BP, Heart Rate Strongly Linked to Death in Chronic Aortic Regurgitation

The Biggest News of 2019: TCTMD’s Top 10

Valve Guidelines: How Effective are They?

Quality with Efficiency 12 by 12

Valve Guidelines- How Effective Are They- - V. Falk

Optimizing the Duration of DAPT following PCI

Looking Beyond the Stent: Optimizing LDL-C Management in Patients Undergoing Revascularization

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content